To Study the Effects of Cordyceps Cicadae on Vision Care

Myopia Clinical Trial

Official title:

To Study the Effects of Cordyceps Cicadae on Vision Care

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05778409
• Other study ID #: CRREC-111-087
• Status: Recruiting
• Phase: Early Phase 1
• Start date: March 8, 2023
• Est. completion date: December 15, 2023

Study information

• Verified date: March 2023
• Source: China Medical University Hospital
• Contact: Hui-Wen Lin, Ph.D
• Phone: 04-23323456
• Email: d9138001[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cordyceps cicadae is a traditional Asian herbal medicine with a variety of bioactive substances and curative effects similar to Cordyceps Cicadae, and it has been reported that anti-dry eye and eye protection ingredients can be extracted. With the advancement of civilization, the number of patients with high myopia is increasing year by year and suffers from complications of dry eye or other eye diseases. In this study, the subjects were provided with cicadae extract or placebo in a double-blind manner, tracked the degree of visual fatigue by regular questionnaires, and measured for visual acuity, axial length and diopter. The purpose of this study is to investigate the effect of cicadae extract on visual acuity and visual fatigue, and to evaluate its potential as a health food ingredient.

Description:

1. Visual acuity measurement: Snellen's Chart was used to measure visual acuity.

2. Refractive examination: Measure binocular refraction with Open Field computer refractor (Shin-Nippon Nvision K5001 Wide View).

3. Measuring the axial length of the eye: Use the multifunctional optical eyeball length measuring instrument (Lenstar) to measure the distance from the instrument to the optical paths such as the cornea, lens, and retina, and then convert to the axial length of the eye.

4. Corneal radian measurement: Use a keratometer (Bausch & Lomb Keratometer) to measure the corneal radian and curvature, and estimate the degree of corneal astigmatism.

5. Visual fatigue questionnaire survey: A visual fatigue scale questionnaire was designed using Ocular Surface Disease Index (OSDI) and Computer Vision Syndrome (CVS).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 15, 2023
• Est. primary completion date: December 15, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

1. Adults aged 20 or over

2. Willing to participate in this study and sign the subject's consent form

3. Myopia less than 700 degrees

Exclusion Criteria:

1. Have consumed related eye care products in past 3 months

2. Those who have eye infection in the past 3 months

3. People who have been diagnosed with any eye diseases in past 3 months

4. Those who are allergic to cicadae

Related Conditions & MeSH terms

• Myopia

Intervention

Biological:
• Cordyceps cicadae extract
500mg/ day for one month

Locations

Country	Name	City	State
Taiwan	Asia university	Taichung

Sponsors (1)

Lead Sponsor	Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Eye fatigue questionnaire	Eye fatigue were evaluated according to The Ocular Surface Disease Index (OSDI) introduced in 1997 by the Outcomes Research Group (Allergan Inc., Irvine, CA).; Content including: (1) Eye swelling, (2) Eye soreness, (3) Photophobia, (4) Blurred vision, (5) Dry eye, (6) Foreign body sensation, (7) Tearing, (8) General discomfort related to eye fatigue.; Scores are expressed on a scale of 0-3. 0 = No symptoms , 1 = Occasionally (=1 time/day), 2 = Sometimes (1-3 times/day), 3 = Frequently (>3 times/day), a low score means less visual fatigue and better eye quality.	one month
Primary	Best vision test	Visual acuity was tested with the Snellen Eye Test Chart and recorded with the score proposed by Snellen.; Subjects were asked to stand 20 feet away to observe the snellen E-chart and record the smallest visual mark.; Recording method: 20/20 (1.0) is defined as normal vision, lower than this score indicates that the subject has ametropia, and higher than this indicates that the subject's vision is higher than the general standard	one month